Chemomab Therapeutics Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $19.8M
Liabilities Breakdown FY2019
Total Liabilities: $4.8M
Asset Breakdown
Total Assets: $19.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.6M | 89.0% |
| Accounts Receivable | $408.0K | 2.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $158.0K | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.6M | 8.2% |
Liabilities Breakdown
Total Liabilities: $4.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $875.0K | 18.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.0M | 81.9% |